Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIRARUBICIN for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 34 adverse event reports in the FDA FAERS database where PIRARUBICIN was used for Neoplasm malignant.

Most Reported Side Effects for PIRARUBICIN

Side Effect Reports % Deaths Hosp.
Myelosuppression 408 30.3% 5 260
White blood cell count decreased 207 15.4% 9 114
Neutrophil count decreased 145 10.8% 3 90
Bone marrow failure 127 9.4% 14 55
Nausea 111 8.2% 2 68
Vomiting 104 7.7% 2 70
Gastrointestinal disorder 58 4.3% 1 39
Leukopenia 55 4.1% 0 21
Pyrexia 55 4.1% 4 36
Neutropenia 54 4.0% 13 18
Febrile neutropenia 53 3.9% 13 16
Decreased appetite 50 3.7% 7 20
Platelet count decreased 43 3.2% 6 21
Anaemia 42 3.1% 6 13
Hepatic function abnormal 41 3.0% 3 11

Other Indications for PIRARUBICIN

Breast cancer female (271) Diffuse large b-cell lymphoma (175) Chemotherapy (135) Breast cancer (82) Lymphoma (68) Invasive ductal breast carcinoma (56) Acute lymphocytic leukaemia (51) Non-hodgkin's lymphoma (40) Neoplasm (38) B-cell lymphoma (36)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

PIRARUBICIN Full Profile All Neoplasm malignant Drugs PIRARUBICIN Demographics PIRARUBICIN Timeline